We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New RNAi Treatment Targets Eye Inflammation

News   Feb 15, 2017 | Original story from Hokkaido University

 
New RNAi Treatment Targets Eye Inflammation

The newly developed RNAi agent suppressed chronic inflammation in the retinas of diabetic mice. The number of leukocytes (arrows) in the inflamed vasculature was significantly reduced in the RNAi-treated retina (right) comparing to the control experiment (left). Credit: Hokkaido University

 
 
 

RELATED ARTICLES

Fruit Fly Gene Study Shows the Complexity of Neurodevelopmental Disorders

News

Researchers have evaluated the effects of genes implicated in neurodevelopmental disorders; the results suggest that the disorders have a complex causation involving many genes.

READ MORE

What Links Larger Brain Ventricles and Schizophrenia?

News

A new study suggests that two microRNAs play a critical role in a mechanism that results in ventricular enlargement in a type of mouse model.

READ MORE

Saving Cells From Ice Damage

News

Researchers have set the stage for designing polymers that can effectively prevent the growth of ice that damages cells during storage.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE